Search Page

1

Cite

Share

Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review.

Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT. Jamnitski A, et al. Ann Rheum Dis. 2013 Feb;72(2):211-6. doi: 10.1136/annrheumdis-2011-201194. Epub 2012 Apr 24. Ann Rheum Dis. 2013. PMID: 22532629 Review.

Cite

Share

2

Cite

Share

MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.

Juge PA, Solomon JJ, van Moorsel CHM, Garofoli R, Lee JS, Louis-Sydney F, Rojas-Serrano J, González-Pérez MI, Mejia M, Buendia-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou KM, Sidiropoulos P, Trachalaki A, van der Vis JJ, Jamnitski A, Grutters JC, Kannengiesser C, Borie R, Kawano-Dourado L, Wemeau-Stervinou L, Flipo RM, Nunes H, Uzunhan Y, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Richez C, Schaeverbeke T, Doyle T, Wolters PJ, Debray MP, Boileau C, Porcher R, Schwartz DA, Crestani B, Dieudé P. Juge PA, et al. Among authors: jamnitski a. Semin Arthritis Rheum. 2021 Oct;51(5):996-1004. doi: 10.1016/j.semarthrit.2021.07.002. Epub 2021 Jul 10. Semin Arthritis Rheum. 2021. PMID: 34411838

Cite

Share

3

Cite

Share

The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept.

Jamnitski A, Bartelds GM, Nurmohamed MT, van Schouwenburg PA, van Schaardenburg D, Stapel SO, Dijkmans BA, Aarden L, Wolbink GJ. Jamnitski A, et al. Ann Rheum Dis. 2011 Feb;70(2):284-8. doi: 10.1136/ard.2010.135111. Epub 2010 Nov 10. Ann Rheum Dis. 2011. PMID: 21068090 Clinical Trial.

Cite

Share

4

Cite

Share

High-density lipoprotein profiling changes in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a cohort study.

Jamnitski A, Levels JH, van den Oever IA, Nurmohamed MT. Jamnitski A, et al. J Rheumatol. 2013 Jun;40(6):825-30. doi: 10.3899/jrheum.121358. Epub 2013 May 1. J Rheumatol. 2013. PMID: 23637327

Cite

Share

5

Cite

Share

Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis.

Jamnitski A, Visman IM, Peters MJ, Boers M, Dijkmans BA, Nurmohamed MT. Jamnitski A, et al. Ann Rheum Dis. 2011 May;70(5):875-6. doi: 10.1136/ard.2010.136499. Epub 2010 Oct 18. Ann Rheum Dis. 2011. PMID: 20956406 No abstract available.

Cite

Share

6

Cite

Share

Symptomatic unilateral sacroiliitis as a first presenting feature of IgG4-related disease with successful response to treatment after 1 year of follow-up article.

Jamnitski A, van Hall O, de Vries N, van der Valk P, Lems WF, van der Horst-Bruinsma IE. Jamnitski A, et al. Rheumatology (Oxford). 2017 Apr 1;56(4):670-671. doi: 10.1093/rheumatology/kew481. Rheumatology (Oxford). 2017. PMID: 28039416 No abstract available.

Cite

Share

7

Cite

Share

Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients.

Jamnitski A, Krieckaert CL, Nurmohamed MT, Hart MH, Dijkmans BA, Aarden L, Voskuyl AE, Wolbink GJ. Jamnitski A, et al. Ann Rheum Dis. 2012 Jan;71(1):88-91. doi: 10.1136/annrheumdis-2011-200184. Epub 2011 Sep 12. Ann Rheum Dis. 2012. PMID: 21914626 Clinical Trial.

Cite

Share

8

Cite

Share

Adalimumab: a new modality for Behçet's disease?

van Laar JA, Missotten T, van Daele PL, Jamnitski A, Baarsma GS, van Hagen PM. van Laar JA, et al. Among authors: jamnitski a. Ann Rheum Dis. 2007 Apr;66(4):565-6. doi: 10.1136/ard.2006.064279. Epub 2006 Nov 23. Ann Rheum Dis. 2007. PMID: 17124248 Free PMC article. No abstract available.

Cite

Share

9

Cite

Share

Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study.

Raterman HG, Jamnitski A, Lems WF, Voskuyl AE, Dijkmans BA, Bos WH, Simsek S, Lips P, van de Stadt RJ, de Koning MH, Nurmohamed MT. Raterman HG, et al. Among authors: jamnitski a. J Rheumatol. 2011 Feb;38(2):247-51. doi: 10.3899/jrheum.100488. Epub 2010 Nov 15. J Rheumatol. 2011. PMID: 21078720

Cite

Share

10

Cite

Share

Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation.

de Vries MK, Brouwer E, van der Horst-Bruinsma IE, Spoorenberg A, van Denderen JC, Jamnitski A, Nurmohamed MT, Dijkmans BA, Aarden LA, Wolbink GJ. de Vries MK, et al. Among authors: jamnitski a. Ann Rheum Dis. 2009 Nov;68(11):1787-8. doi: 10.1136/ard.2009.109702. Ann Rheum Dis. 2009. PMID: 19822712 No abstract available.

Cite

Share